Management of Chronic Nightmares in a 15-Year-Old
Image rehearsal therapy (IRT) is the recommended first-line treatment for this adolescent with chronic nightmares, as it has the strongest evidence base for nightmare disorder in both PTSD and non-PTSD populations and can significantly improve quality of life by reducing nightmare frequency and associated distress 1.
Initial Assessment
Before initiating treatment, determine:
- Functional impairment: Is the patient experiencing mood disturbance, sleep resistance, cognitive impairments, behavioral problems (bedtime avoidance, fear of dark), daytime sleepiness, fatigue, or impaired school/social function? 1
- Trauma history: Screen for PTSD or trauma exposure, as this may influence treatment selection
- Medication review: Identify any drugs affecting norepinephrine, serotonin, dopamine, GABA, or acetylcholine that could be causing nightmares 1
- Comorbid conditions: Assess for depression, anxiety, substance use, or other psychiatric disorders 1
Treatment Algorithm
First-Line: Image Rehearsal Therapy (IRT)
IRT is the only treatment with a "recommended" designation from the American Academy of Sleep Medicine for nightmare disorder 1. This modified cognitive behavioral therapy involves:
- Recalling and writing down the nightmare
- Changing the content to a more positive scenario (theme, storyline, or ending)
- Rehearsing the rewritten dream for 10-20 minutes daily while awake 1
Evidence supporting IRT in adolescents: Recent studies demonstrate significant efficacy in youth populations. A 2024 telehealth study of 46 youth aged 6-17 with chronic nightmares showed statistically significant improvements with CBT-based nightmare treatment including IRT principles: nightmare frequency reduced (Cohen's d = 0.82), nightmare distress decreased (Cohen's d = 1.05), and nights with awakening improved (Cohen's d = 1.08) 2. The treatment also improved internalizing/externalizing problems and suicidal ideation 2.
Delivery format: IRT can be delivered in as few as one 2.5-hour session or three sessions (two 3-hour sessions one week apart with 1-hour follow-up) 1. Telehealth delivery is effective 2.
Second-Line Options
If IRT is unavailable or ineffective, consider:
Behavioral/Psychological Interventions (all "may be used" designation):
- Cognitive behavioral therapy (CBT) for nightmares
- Exposure, relaxation, and rescripting therapy (ERRT)
- Progressive deep muscle relaxation
- Lucid dreaming therapy 1
Pharmacological Options (if behavioral interventions fail):
While the AASM guidelines focus on adults [1-3], emerging pediatric evidence supports:
- Prazosin: A 2026 case report demonstrated complete remission in an adolescent with chronic PTSD-related nightmares using prazosin 3 mg nightly, with UCLA PTSD scores declining from 61 to 11 over 20 weeks after failing multiple other medications 4. For nightmare disorder without PTSD, prazosin "may be used" per adult guidelines 1
Important caveat: The adult guidelines note that clonazepam and venlafaxine are not recommended for nightmare disorder 1.
Clinical Pitfalls to Avoid
Don't dismiss long-standing nightmares as "just dreams": This patient has had nightmares for 13 years, which significantly impacts quality of life and may be associated with or predispose to psychiatric disorders 1
Don't start with medication: Behavioral interventions, particularly IRT, have stronger evidence and no side effects. The 2023 systematic review emphasizes that treatments are most effective when they facilitate mastery by directly targeting nightmare content 5
Don't overlook trauma: Even if the patient doesn't meet full PTSD criteria, trauma-focused elements may be beneficial. Up to 80% of PTSD patients have nightmares, and nightmares following trauma predict PTSD onset 1
Don't ignore sleep hygiene: Address maladaptive sleep habits and sleep deprivation, which perpetuate nightmares 6
Don't forget the family: Nightmares cause "negative impact on caregiver or family functioning" and addressing family disruption is part of comprehensive care 1
Evidence Strength Considerations
The AASM position paper acknowledges "limited direct evidence for many available treatment options" 1, which is why most treatments receive "may be used" rather than "recommended" designations. However, IRT stands alone with the strongest recommendation based on multiple RCTs showing sustained benefit at 6-month and 18-month follow-up 1.
The pediatric literature is emerging but promising, with 2024-2025 studies showing strong effect sizes for CBT-based nightmare interventions in youth 2, 7. A 2023 systematic review of 69 studies provides "strong evidence for exposure and image rehearsal treatments" across all cohorts 5.
Treatment Expectations
Patients successfully treated for nightmares report:
- Better sleep quality
- Reduced insomnia symptoms
- Less daytime fatigue and sleepiness
- Feeling more rested upon awakening 1
Treatment effects can be rapid—the prazosin case showed improvement within weeks 4, and school-based IRT interventions showed week-to-week reductions with 42% nightmare-free at 10-month follow-up 7.